Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9FX1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,221
Award facts
- Contract value 100% obligated
- $23,221.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $23,221.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This is a non-set-aside contract with an ultimate completion date of December 16, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. RINVOQ ER is a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions, representing the type of specialty pharmaceutical product that the Defense Logistics Agency routinely procures for military and veteran healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of pharmaceutical products and medical supplies serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract was competitively awarded, reflecting the contractor's demonstrated capability to meet federal procurement requirements and supply critical medical commodities to support military healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26F9FX1?
SPE2DR26F9FX1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26F9FX1 worth?
The government has obligated $23,221 on SPE2DR26F9FX1.
Is contract SPE2DR26F9FX1 an order under another contract?
Yes. SPE2DR26F9FX1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9FX1 competed?
The extent of competition for SPE2DR26F9FX1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award